Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Cellulitis peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Cellulitis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
2 profiles.
2014–2018 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 55 selected PubMed records and 38 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Cellulitis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01339091
PeptideScanner retained ClinicalTrials.gov record NCT01339091 at 2026-11-16T17:37:42.807Z. Its registry update date was 2014-01-31, and PeptideScanner's reviewed identity mapping was dalbavancin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- January 31, 2014
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02127970
PeptideScanner retained ClinicalTrials.gov record NCT02127970 at 2026-11-16T17:37:42.807Z. Its registry update date was 2018-09-28, and PeptideScanner's reviewed identity mapping was dalbavancin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 28, 2018
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00295178
PeptideScanner retained ClinicalTrials.gov record NCT00295178 at 2026-11-15T22:01:45.056Z. Its registry update date was 2017-09-07, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- September 7, 2017
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Dalbavancin · 2018-09-28
ClinicalTrials.gov record NCT02127970
Completed at the retained observation.
Open attributed record →Daptomycin · 2017-09-07
ClinicalTrials.gov record NCT00295178
Completed at the retained observation.
Open attributed record →Daptomycin · 2015-03-20
ClinicalTrials.gov record NCT01626560
Completed at the retained observation.
Open attributed record →Daptomycin · 2014-08-01
ClinicalTrials.gov record NCT01549613
Completed at the retained observation.
Open attributed record →Dalbavancin · 2014-01-31
ClinicalTrials.gov record NCT01339091
Completed at the retained observation.
Open attributed record →